Breaking News Instant updates and real-time market news.

GOL

Gol Linhas

$8.70 /

-0.09 (-1.02%)

06:58
01/08/21
01/08
06:58
01/08/21
06:58

Gol Linhas provides December investor update

GOL Linhas provided its investor update for the month of December of 2020. Since the last monthly update on December 7, 2020, GOL increased its capacity to an average of 476 flights per day, a 29% increase from an average of 369 daily flights in November. On peak days, the company operated approximately 610 daily flights in December to meet the increase in demand for air travel. This month, GOL reached a new record of passengers transported since the beginning of the pandemic with more than 89,000 Customers served in a single day. GOL's consolidated gross revenues for the month were R$852M and the average load factor was 81%, very consistent in relation to previous months. The high season network, in operation between December 18, 2020 and January 31, 2021, will offer an average of 558 daily flights, to serve the demand of customers who wish to fly for the holidays and summer vacation. Matching capacity to demand allows GOL to maintain flexibility to respond to the prevailing demand trends. December 2020 showed continued demand recovery over November 2020 and provided better visibility into Q1. GOL expects to end Q1 at approximately 70% of the level of capacity and demand as it had at the end of 1Q20, with a consistent and profitable average load factor, above 80%. In January, GOL is increasing its capacity to approximately 550 flights per day, and nearly 620 daily flights on peak days, placing the company's operations at over 65% of the domestic flight schedule in January 2020. During this current month, GOL will be operating 92 aircraft in its network. The company's aircraft contracts are adjusted to meet the expected recovery of demand in 2021 and also will provide an effective reduction in GOL's unit operating costs. Additionally, The company has reduced its fixed costs by converting a portion of its monthly lease payments to variable power-by-the-hour. For Q4, GOL expects to maintain personnel costs reduced at up to 40% of pre-pandemic levels. Having converted a significant portion of fixed payroll and fleet costs into variable costs, the company is positioned to expand its unit cost leadership

GOL Gol Linhas
$8.70 /

-0.09 (-1.02%)

12/21/20 Grupo Santander
Gol Linhas downgraded to Hold from Buy at Santander
12/10/20 Raymond James
Gol Linhas downgraded to Market Perform from Outperform at Raymond James
12/07/20 Citi
Citi ups Gol Linhas target to $16, opens '30-day positive catalyst watch'
11/09/20 Seaport Global
Azul upgraded to Buy from Neutral at Seaport Global

TODAY'S FREE FLY STORIES

Initiation
Opco starts Oaktree Specialty Lending with an Outperform on 'strong' credit » 17:08
06/23/21
06/23
17:08
06/23/21
17:08
OCSL

Oaktree Specialty Lending

$6.74 /

+0.025 (+0.37%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

16:23 Today Oppenheimer
Oaktree Specialty Lending initiated with an Outperform at Oppenheimer
03/05/21 Hovde Group
Oaktree Specialty Lending initiated with an Outperform at Hovde Group
OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

Conference/Events
Fulcrum Therapeutics to host conference call » 17:05
06/23/21
06/23
17:05
06/23/21
17:05
FULC

Fulcrum Therapeutics

$9.13 /

+0.25 (+2.82%)

Management discusses the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

04/26/21 Credit Suisse
Fulcrum Therapeutics assumed with an Outperform at Credit Suisse
03/22/21 Credit Suisse
Fulcrum Therapeutics initiated with an Outperform at Credit Suisse
03/04/21 Piper Sandler
Fulcrum Therapeutics price target lowered to $20 from $22 at Piper Sandler
03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

  • 20
    Jan
Hot Stocks
Celanese acquires POM technology, sales agreements from Grupa Azoty » 17:00
06/23/21
06/23
17:00
06/23/21
17:00
CE

Celanese

$148.72 /

+0.105 (+0.07%)

Celanese Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CE Celanese
$148.72 /

+0.105 (+0.07%)

CE Celanese
$148.72 /

+0.105 (+0.07%)

06/21/21 Baird
Celanese remains a top pick at Baird
06/09/21 Wolfe Research
Celanese initiated with an Outperform at Wolfe Research
06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 Goldman Sachs
Celanese downgraded to Neutral from Buy at Goldman Sachs
CE Celanese
$148.72 /

+0.105 (+0.07%)

CE Celanese
$148.72 /

+0.105 (+0.07%)

CE Celanese
$148.72 /

+0.105 (+0.07%)

Syndicate
Portage Biotech files $200M mixed securities shelf » 17:00
06/23/21
06/23
17:00
06/23/21
17:00
PRTG

Portage Biotech

$35.28 /

+2.38 (+7.23%)

Cantor Fitzgerald and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Gold Royalty to hold a town hall meeting » 16:59
06/23/21
06/23
16:59
06/23/21
16:59
GROY

Gold Royalty

$5.64 /

+0.135 (+2.45%)

President & CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GROY Gold Royalty
$5.64 /

+0.135 (+2.45%)

GROY Gold Royalty
$5.64 /

+0.135 (+2.45%)

04/15/21 H.C. Wainwright
Gold Royalty initiated with a Buy at H.C. Wainwright
  • 09
    Mar
GROY Gold Royalty
$5.64 /

+0.135 (+2.45%)

GROY Gold Royalty
$5.64 /

+0.135 (+2.45%)

Initiation
Reynolds Consumer Products initiated with a Neutral at UBS » 16:57
06/23/21
06/23
16:57
06/23/21
16:57
REYN

Reynolds Consumer Products

$29.73 /

-0.24 (-0.80%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REYN Reynolds Consumer Products
$29.73 /

-0.24 (-0.80%)

02/11/21 Citi
Reynolds Consumer Products price target lowered to $33 from $35 at Citi
01/28/21 Stifel
Reynolds Consumer Products price target lowered to $35 from $40 at Stifel
01/04/21 RBC Capital
Reynolds Consumer Products upgraded to Outperform from Sector Perform at RBC Capital
01/04/21 RBC Capital
Reynolds Consumer upgraded to Outperform from Sector Perform at RBC Capital
REYN Reynolds Consumer Products
$29.73 /

-0.24 (-0.80%)

Initiation
Yeti initiated with a Neutral at UBS » 16:57
06/23/21
06/23
16:57
06/23/21
16:57
YETI

Yeti

$89.47 /

-0.57 (-0.63%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$89.47 /

-0.57 (-0.63%)

YETI Yeti
$89.47 /

-0.57 (-0.63%)

06/14/21 Exane BNP Paribas
Yeti initiated with an Outperform at Exane BNP Paribas
05/14/21 BofA
Yeti price target raised to $105 from $88 at BofA
05/14/21 Credit Suisse
Yeti price target raised to $105 from $85 at Credit Suisse
05/14/21 KeyBanc
Yeti price target raised to $94 from $80 at KeyBanc
YETI Yeti
$89.47 /

-0.57 (-0.63%)

YETI Yeti
$89.47 /

-0.57 (-0.63%)

YETI Yeti
$89.47 /

-0.57 (-0.63%)

YETI Yeti
$89.47 /

-0.57 (-0.63%)

Initiation
Church & Dwight initiated with a Neutral at UBS » 16:56
06/23/21
06/23
16:56
06/23/21
16:56
CHD

Church & Dwight

$83.04 /

-0.92 (-1.10%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$83.04 /

-0.92 (-1.10%)

CHD Church & Dwight
$83.04 /

-0.92 (-1.10%)

04/19/21
Fly Intel: Top five analyst downgrades
04/19/21 Morgan Stanley
Church & Dwight downgraded to Underweight from Equal Weight at Morgan Stanley
04/16/21 JPMorgan
Church & Dwight price target raised to $80 from $79 at JPMorgan
12/07/20 Wells Fargo
Church & Dwight initiated with an Equal Weight at Wells Fargo
CHD Church & Dwight
$83.04 /

-0.92 (-1.10%)

CHD Church & Dwight
$83.04 /

-0.92 (-1.10%)

Initiation
Kimberly-Clark initiated with a Neutral at UBS » 16:56
06/23/21
06/23
16:56
06/23/21
16:56
KMB

Kimberly-Clark

$130.28 /

+0.16 (+0.12%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMB Kimberly-Clark
$130.28 /

+0.16 (+0.12%)

KMB Kimberly-Clark
$130.28 /

+0.16 (+0.12%)

05/14/21 Wells Fargo
Kimberly-Clark upgraded to Equal Weight from Underweight at Wells Fargo
05/14/21 Wells Fargo
Kimberly-Clark upgraded to Equal Weight from Underweight at Wells Fargo
04/26/21 RBC Capital
Kimberly-Clark price target lowered to $137 from $147 at RBC Capital
04/26/21 Jefferies
Kimberly-Clark price target lowered to $150 from $160 at Jefferies
KMB Kimberly-Clark
$130.28 /

+0.16 (+0.12%)

KMB Kimberly-Clark
$130.28 /

+0.16 (+0.12%)

Initiation
Estee Lauder initiated with a Neutral at UBS » 16:55
06/23/21
06/23
16:55
06/23/21
16:55
EL

Estee Lauder

$302.41 /

+1.83 (+0.61%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EL Estee Lauder
$302.41 /

+1.83 (+0.61%)

EL Estee Lauder
$302.41 /

+1.83 (+0.61%)

05/04/21 Evercore ISI
Estee Lauder shares should be bought on dip, says Evercore ISI
05/04/21 DA Davidson
Estee Lauder price target raised to $367 from $348 at DA Davidson
05/04/21 JPMorgan
Estee Lauder added to Analyst Focus List after selloff at JPMorgan
05/04/21 Deutsche Bank
Estee Lauder price target lowered to $320 from $337 at Deutsche Bank
EL Estee Lauder
$302.41 /

+1.83 (+0.61%)

EL Estee Lauder
$302.41 /

+1.83 (+0.61%)

EL Estee Lauder
$302.41 /

+1.83 (+0.61%)

EL Estee Lauder
$302.41 /

+1.83 (+0.61%)

Initiation
Procter & Gamble initiated with a Neutral at UBS » 16:55
06/23/21
06/23
16:55
06/23/21
16:55
PG

Procter & Gamble

$132.89 /

-0.225 (-0.17%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PG Procter & Gamble
$132.89 /

-0.225 (-0.17%)

PG Procter & Gamble
$132.89 /

-0.225 (-0.17%)

04/21/21
Fly Intel: Top five analyst downgrades
04/21/21 Roth Capital
PureCycle Technologies initiated with a Buy at Roth Capital
04/21/21 Citi
Procter & Gamble downgraded to Neutral from Buy at Citi
04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
PG Procter & Gamble
$132.89 /

-0.225 (-0.17%)

PG Procter & Gamble
$132.89 /

-0.225 (-0.17%)

PG Procter & Gamble
$132.89 /

-0.225 (-0.17%)

PG Procter & Gamble
$132.89 /

-0.225 (-0.17%)

Initiation
Hydrofarm initiated with a Buy at UBS » 16:54
06/23/21
06/23
16:54
06/23/21
16:54
HYFM

Hydrofarm

$54.99 /

-0.5 (-0.90%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HYFM Hydrofarm
$54.99 /

-0.5 (-0.90%)

HYFM Hydrofarm
$54.99 /

-0.5 (-0.90%)

03/31/21 Deutsche Bank
Hydrofarm price target lowered to $77 from $88 at Deutsche Bank
02/22/21 Truist
Hydrofarm price target raised to $95 from $65 at Truist
01/04/21 William Blair
Hydrofarm initiated with an Outperform at William Blair
01/04/21 Truist
Hydrofarm initiated with a Buy at Truist
HYFM Hydrofarm
$54.99 /

-0.5 (-0.90%)

  • 29
    Apr
  • 10
    Dec
HYFM Hydrofarm
$54.99 /

-0.5 (-0.90%)

HYFM Hydrofarm
$54.99 /

-0.5 (-0.90%)

Initiation
Spectrum Brands initiated with a Buy at UBS » 16:54
06/23/21
06/23
16:54
06/23/21
16:54
SPB

Spectrum Brands

$82.07 /

-0.64 (-0.77%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPB Spectrum Brands
$82.07 /

-0.64 (-0.77%)

SPB Spectrum Brands
$82.07 /

-0.64 (-0.77%)

05/10/21 Monness Crespi
Spectrum Brands price target raised to $113 from $100 at Monness Crespi
05/10/21 Wells Fargo
Spectrum Brands price target raised to $115 from $105 at Wells Fargo
05/10/21 Deutsche Bank
Spectrum Brands price target raised to $108 from $104 at Deutsche Bank
03/29/21 Wells Fargo
Spectrum Brands price target raised to $105 from $95 at Wells Fargo
SPB Spectrum Brands
$82.07 /

-0.64 (-0.77%)

Initiation
Scotts Miracle-Gro initiated with a Buy at UBS » 16:54
06/23/21
06/23
16:54
06/23/21
16:54
SMG

Scotts Miracle-Gro

$191.57 /

-5.255 (-2.67%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMG Scotts Miracle-Gro
$191.57 /

-5.255 (-2.67%)

SMG Scotts Miracle-Gro
$191.57 /

-5.255 (-2.67%)

07:30 Today Raymond James
Scotts Miracle-Gro price target lowered to $250 from $305 at Raymond James
05/06/21 Truist
Scotts Miracle-Gro price target raised to $300 from $275 at Truist
04/09/21 Truist
Scotts Miracle-Gro price target raised to $275 from $270 at Truist
04/09/21 Raymond James
Scotts Miracle-Gro price target raised to $300 from $290 at Raymond James
SMG Scotts Miracle-Gro
$191.57 /

-5.255 (-2.67%)

SMG Scotts Miracle-Gro
$191.57 /

-5.255 (-2.67%)

Conference/Events
Intellia Therapeutics to host conference call » 16:53
06/23/21
06/23
16:53
06/23/21
16:53
NTLA

Intellia Therapeutics

$83.61 /

+4.65 (+5.89%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$83.61 /

+4.65 (+5.89%)

NTLA Intellia Therapeutics
$83.61 /

+4.65 (+5.89%)

06:49 Today Baird
Intellia Therapeutics price target raised to $85 from $60 at Baird
06:09 Today JMP Securities
Intellia Therapeutics price target raised to $88 from $80 at JMP Securities
06/22/21 Jefferies
Intellia price target raised to $109 at Jefferies ahead of '2001 data report
06/11/21
Fly Intel: Top five analyst initiations
NTLA Intellia Therapeutics
$83.61 /

+4.65 (+5.89%)

  • 02
    Dec
Initiation
Newell Brands initiated with a Buy at UBS » 16:53
06/23/21
06/23
16:53
06/23/21
16:53
NWL

Newell Brands

$26.43 /

-0.09 (-0.34%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NWL Newell Brands
$26.43 /

-0.09 (-0.34%)

NWL Newell Brands
$26.43 /

-0.09 (-0.34%)

05/03/21 Truist
Newell Brands price target raised to $35 from $30 at Truist
05/03/21 Deutsche Bank
Newell Brands price target raised to $26 from $24 at Deutsche Bank
04/16/21 JPMorgan
Newell Brands price target raised to $28 from $26 at JPMorgan
02/16/21 Truist
Newell Brands price target raised to $30 from $25 at Truist
NWL Newell Brands
$26.43 /

-0.09 (-0.34%)

NWL Newell Brands
$26.43 /

-0.09 (-0.34%)

Initiation
Colgate-Palmolive initiated with a Buy at UBS » 16:52
06/23/21
06/23
16:52
06/23/21
16:52
CL

Colgate-Palmolive

$80.27 /

-0.99 (-1.22%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CL Colgate-Palmolive
$80.27 /

-0.99 (-1.22%)

CL Colgate-Palmolive
$80.27 /

-0.99 (-1.22%)

06/09/21
Fly Intel: Top five analyst upgrades
06/09/21 Credit Suisse
Colgate-Palmolive upgraded to Outperform from Neutral at Credit Suisse
05/03/21 Deutsche Bank
Colgate-Palmolive price target raised to $85 from $84 at Deutsche Bank
04/16/21 JPMorgan
Colgate-Palmolive price target lowered to $85 from $87 at JPMorgan
CL Colgate-Palmolive
$80.27 /

-0.99 (-1.22%)

CL Colgate-Palmolive
$80.27 /

-0.99 (-1.22%)

CL Colgate-Palmolive
$80.27 /

-0.99 (-1.22%)

Hot Stocks
FTAC Olympus Acquisition shareholders approve Payoneer business combination » 16:49
06/23/21
06/23
16:49
06/23/21
16:49
FTOC

FTAC Olympus Acquisition

$10.37 /

+0.115 (+1.12%)

, PAYO

Payoneer Global

/

+

FTAC Olympus Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTOC FTAC Olympus Acquisition
$10.37 /

+0.115 (+1.12%)

FTOC FTAC Olympus Acquisition
$10.37 /

+0.115 (+1.12%)

06/03/21 Northland
FTAC Olympus Acquisition initiated with an Outperform at Northland
PAYO Payoneer Global
/

+

FTOC FTAC Olympus Acquisition
$10.37 /

+0.115 (+1.12%)

FTOC FTAC Olympus Acquisition
$10.37 /

+0.115 (+1.12%)

FTOC FTAC Olympus Acquisition
$10.37 /

+0.115 (+1.12%)

Conference/Events
Redwood Trust participates in a webcast with Raymond James » 16:48
06/23/21
06/23
16:48
06/23/21
16:48
RWT

Redwood Trust

$12.16 /

+0.07 (+0.58%)

Director of Equity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RWT Redwood Trust
$12.16 /

+0.07 (+0.58%)

RWT Redwood Trust
$12.16 /

+0.07 (+0.58%)

06/15/21 BTIG
Redwood Trust price target raised to $13.50 from $12.50 at BTIG
12/18/20 Keefe Bruyette
Redwood Trust upgraded to Outperform from Market Perform at Keefe Bruyette
12/14/20 Jefferies
Redwood Trust initiated with a Buy at Jefferies
11/23/20 BTIG
Redwood Trust initiated with a Buy at BTIG
RWT Redwood Trust
$12.16 /

+0.07 (+0.58%)

Initiation
Clorox initiated with a Sell at UBS » 16:46
06/23/21
06/23
16:46
06/23/21
16:46
CLX

Clorox

$172.65 /

-1.83 (-1.05%)

UBS analyst Peter Grom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLX Clorox
$172.65 /

-1.83 (-1.05%)

CLX Clorox
$172.65 /

-1.83 (-1.05%)

16:30 Today UBS
Clorox initiated with a Sell at UBS
05/21/21 Argus
Clorox price target lowered to $206 from $230 at Argus
05/04/21 Jefferies
Clorox price target lowered to $195 from $205 at Jefferies
05/03/21
Fly Intel: Top five analyst downgrades
CLX Clorox
$172.65 /

-1.83 (-1.05%)

CLX Clorox
$172.65 /

-1.83 (-1.05%)

CLX Clorox
$172.65 /

-1.83 (-1.05%)

CLX Clorox
$172.65 /

-1.83 (-1.05%)

Hot Stocks
NYDIG, Q2 to offer bitcoin solutions for financial institutions » 16:39
06/23/21
06/23
16:39
06/23/21
16:39
QTWO

Q2 Holdings

$107.37 /

+0.59 (+0.55%)

, BTC

Bitcoin

/

+

, BITCOIN

Bitcoin

/

+

, $BTC

Bitcoin

/

+

NYDIG and Q2 Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QTWO Q2 Holdings
$107.37 /

+0.59 (+0.55%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

$BTC Bitcoin
/

+

QTWO Q2 Holdings
$107.37 /

+0.59 (+0.55%)

05/13/21 DA Davidson
Q2 Holdings upgraded to Buy at DA Davidson on valuation
05/13/21 DA Davidson
Q2 Holdings upgraded to Buy from Neutral at DA Davidson
04/05/21 Gabelli
Q2 Holdings upgraded to Buy from Hold at Gabelli
02/23/21 Canaccord
Q2 Holdings price target raised to $155 from $116 at Canaccord
BTC Bitcoin
/

+

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
$BTC Bitcoin
/

+

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
QTWO Q2 Holdings
$107.37 /

+0.59 (+0.55%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

$BTC Bitcoin
/

+

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

$BTC Bitcoin
/

+

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

$BTC Bitcoin
/

+

Syndicate
Talos Energy announces 5M share offering of common stock for holders » 16:35
06/23/21
06/23
16:35
06/23/21
16:35
TALO

Talos Energy

$18.60 /

+0.47 (+2.59%)

Talos Energy announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Citi
Talos Energy initiated with a Buy at Citi
05/03/21 Roth Capital
Talos Energy price target raised to $18 from $13 at Roth Capital
04/13/21 Stifel
BP discovery holds over 100MMboe of potential net to Talos interest, says Stifel
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

  • 09
    Dec
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

Hot Stocks
Medical Properties Trust to buy five hospitals from Tenet Healthcare for $900M » 16:33
06/23/21
06/23
16:33
06/23/21
16:33
MPW

Medical Properties Trust

$20.26 /

-0.115 (-0.56%)

, THC

Tenet Healthcare

$68.03 /

-0.36 (-0.53%)

Medical Properties Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPW Medical Properties Trust
$20.26 /

-0.115 (-0.56%)

THC Tenet Healthcare
$68.03 /

-0.36 (-0.53%)

MPW Medical Properties Trust
$20.26 /

-0.115 (-0.56%)

06/14/21 Wolfe Research
Medical Properties Trust initiated with a Peer Perform at Wolfe Research
06/03/21 Deutsche Bank
Medical Properties Trust price target raised to $27 from $25 at Deutsche Bank
05/03/21 RBC Capital
RBC Capital cuts Medical Properties Trust to Sector Perform, focusing on offense
05/03/21 RBC Capital
Medical Properties downgraded to Sector Perform from Outperform at RBC Capital
THC Tenet Healthcare
$68.03 /

-0.36 (-0.53%)

06/17/21 Raymond James
Tenet Healthcare price target raised to $90 from $85 at Raymond James
05/05/21 Mizuho
Tenet Healthcare price target raised to $70 from $55 at Mizuho
05/03/21
Fly Intel: Top five analyst initiations
05/03/21 Goldman Sachs
Tenet Healthcare reinstated with a Buy at Goldman Sachs
MPW Medical Properties Trust
$20.26 /

-0.115 (-0.56%)

THC Tenet Healthcare
$68.03 /

-0.36 (-0.53%)

  • 07
    Jan
MPW Medical Properties Trust
$20.26 /

-0.115 (-0.56%)

MPW Medical Properties Trust
$20.26 /

-0.115 (-0.56%)

THC Tenet Healthcare
$68.03 /

-0.36 (-0.53%)

Hot Stocks
Franklin Street announces $50M share repurchase program » 16:32
06/23/21
06/23
16:32
06/23/21
16:32
FSP

Franklin Street

$5.27 /

-0.13 (-2.41%)

CEO George J. Carter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSP Franklin Street
$5.27 /

-0.13 (-2.41%)

Hot Stocks
MarinOne integrates with Instacart Ads » 16:31
06/23/21
06/23
16:31
06/23/21
16:31
MRIN

Marin Software

$1.67 /

+ (+0.00%)

Marin Software has added…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.